GGrantIndex
← Leaderboards

Peter S Linsley

Benaroya Research Inst At Virginia Mason

Google Scholar ↗PubMed ↗ORCID ↗
$7,467,441
Attributed
$12,269,773
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY2013–25
$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,269,773 · 8

By mechanism

R01$7,638,294 · 2
U19$1,765,460 · 3
DP3$1,605,982 · 2
U01$1,260,037 · 1

Top collaborators

Most similar at Benaroya Research Inst At Virginia Mason

Same institution · by research overlap

Others in their field

Top investigators on “Immune”

Research focus

ImmuneCellsTranscriptome SequencingPhenotypeAntigensBiological MarkersT-LymphocyteSingle-Cell Rna SequencingSamplingAntigen-Specific T CellsHeterogeneityCytometryPropertyAllergic DiseaseFrequenciesPlayCd8-Positive T-LymphocytesCohortAutoantigensT-Cell ReceptorTranscriptomeAutoimmune DiseasesLongitudinal CohortAutoimmunity

Grant awards (21)

Clonal expansion: a marker of disease activity in stage 1 T1D$1,259,153
R01 · FY2025 · DK
Systems Immunology profiling of respiratory viral infections in vulnerable populations$310,392
U19 · FY2025 · AI · contact PI
Clonal expansion: a marker of disease activity in stage 1 T1D$1,273,578
R01 · FY2024 · DK
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$465,623
R01 · FY2024 · CA
Systems Immunology profiling of respiratory viral infections in vulnerable populations$420,253
U19 · FY2024 · AI · contact PI
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$845,601
R01 · FY2023 · CA
Anti-tumor and autoimmunity signatures in Down syndrome$648,776
R01 · FY2023 · CA
Systems Immunology profiling of respiratory viral infections in vulnerable populations$335,581
U19 · FY2023 · AI · contact PI
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$901,309
R01 · FY2022 · CA
Systems Immunology profiling of respiratory viral infections in vulnerable populations$326,266
U19 · FY2022 · AI · contact PI
Allergen T cell epitopes during the management of peanut allergic disease$88,460
U19 · FY2022 · AI · contact PI
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$423,377
R01 · FY2021 · CA
Allergen T cell epitopes during the management of peanut allergic disease$109,687
U19 · FY2021 · AI · contact PI
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$946,097
R01 · FY2020 · CA
Allergen T cell epitopes during the management of peanut allergic disease$4,058
U19 · FY2020 · AI · contact PI
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$874,780
R01 · FY2019 · CA
Allergen T cell epitopes during the management of peanut allergic disease$84,629
U19 · FY2019 · AI · contact PI
Allergen T cell epitopes during the management of peanut allergic disease$86,134
U19 · FY2018 · AI · contact PI
Single Cell Transcriptome Analysis of Islet Antigen Reactive Memory CD4+ T Cells in Establshed T1D$510,000
DP3 · FY2016 · DK · contact PI
Determining the molecular basis for different rates of T1D progression$1,095,982
DP3 · FY2014 · DK · contact PI
Blood Transcriptional Biomarker Profiles for Category B Pathogens$1,260,037
U01 · FY2013 · AI · contact PI